These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4500456)

  • 1. Diphenylhydantoin reverses membrane effects in steroid myopathy.
    Gruener RP; Stern LZ
    Nat New Biol; 1972 Jan; 235(54):54-5. PubMed ID: 4500456
    [No Abstract]   [Full Text] [Related]  

  • 2. [A comparison between ouabain treated and genetically dystrophic mice with reference to the effect of phenytoin on the membrane potential of their skeletal muscles (author's transl)].
    Komatsu K; Sato M
    Yakugaku Zasshi; 1979 Aug; 99(8):855-8. PubMed ID: 541777
    [No Abstract]   [Full Text] [Related]  

  • 3. Electrophysiological effects of diphenylhydantoin on canine purkinje fibers.
    Bigger JT; Bassett AL; Hoffman BF
    Circ Res; 1968 Feb; 22(2):221-36. PubMed ID: 5639040
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reversal by phenytoin (diphenylhydantoin) of the resting membrane potential of skeletal muscle from genetically dystrophic mice (author's transl)].
    Ozawa H; Komatsu K; Sato M
    Yakugaku Zasshi; 1978 Mar; 98(3):386-9. PubMed ID: 650419
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of diphenylhydantoin on membrane potentials and NaK-ATPase of cultured chick heart cells.
    Sperelakis N; Henn FA
    Am J Physiol; 1970 Apr; 218(4):1224-7. PubMed ID: 4244883
    [No Abstract]   [Full Text] [Related]  

  • 6. Stabilization of excitable membrane by chronic administration of diphenylhydantoin.
    Julien RM; Halpern LM
    J Pharmacol Exp Ther; 1970 Oct; 175(1):206-12. PubMed ID: 5471447
    [No Abstract]   [Full Text] [Related]  

  • 7. Diphenylhydantoin: excitability reducing action in single myelinated nerve fibres.
    Schwarz JR; Vogel W
    Eur J Pharmacol; 1977 Aug; 44(3):241-9. PubMed ID: 891603
    [No Abstract]   [Full Text] [Related]  

  • 8. "Protective" action of diphenylhydantoin on canine Purkinje fibers during hypoxia.
    Bassett AL; Bigger JT; Hoffman BF
    J Pharmacol Exp Ther; 1970 Jun; 173(2):336-43. PubMed ID: 5434018
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of combinations of diphenylhydantoin and ouabain on the transmembrane potential and developed tension of guinea-pig ventricle.
    Hollander PB; Sakai KK
    Arch Int Pharmacodyn Ther; 1974 May; 209(1):172-85. PubMed ID: 4416186
    [No Abstract]   [Full Text] [Related]  

  • 10. Corticosteroids. Effects on muscle membrane excitability.
    Gruener R; Stern LZ
    Arch Neurol; 1972 Feb; 26(2):181-5. PubMed ID: 5008323
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of diphenylhydantoin on the electrogenic component of the sodium pump in mammalian non-myelinated nerve fibres.
    den Hertog A
    Eur J Pharmacol; 1972 Jul; 19(1):94-7. PubMed ID: 5048664
    [No Abstract]   [Full Text] [Related]  

  • 12. Electrophysiological actions of diphenylhydantoin on rabbit atria. Dependence on stimulation frequency, potassium, and sodium.
    Jensen RA; Katzung BG
    Circ Res; 1970 Jan; 26(1):17-27. PubMed ID: 5410092
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenytoin action on the excitable membrane of mouse neuroblastoma.
    Tuttle JB; Richelson E
    J Pharmacol Exp Ther; 1979 Dec; 211(3):632-7. PubMed ID: 512924
    [No Abstract]   [Full Text] [Related]  

  • 14. The mechanism of action of diphenylhydantoin or invertebrate neurons. I. Effects on basic membrane properties.
    Ayala GF; Lin S; Johnston D
    Brain Res; 1977 Feb; 121(2):245-58. PubMed ID: 832162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cellular mode of action of the anti-epileptic drug 5,5-diphenylhydantoin.
    Perry JG; McKinney L; De Weer P
    Nature; 1978 Mar; 272(5650):271-3. PubMed ID: 305009
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental steroid myopathy].
    Ueta K; Nakata T; Ito T; Oara T
    Nihon Rinsho; 1972 Jan; 30(1):171-6. PubMed ID: 4556869
    [No Abstract]   [Full Text] [Related]  

  • 17. Steroid-induced weakness in patients with primary brain tumors.
    Dropcho EJ; Soong SJ
    Neurology; 1991 Aug; 41(8):1235-9. PubMed ID: 1866012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenytoin: blockage of resting sodium channels.
    De Weer P
    Adv Neurol; 1980; 27():353-61. PubMed ID: 6246764
    [No Abstract]   [Full Text] [Related]  

  • 19. Diphenylhydantoin inhibits ionic excitation of mouse neuroblastoma cells.
    Richelson E; Tuttle JB
    Brain Res; 1975 Nov; 99(1):209-12. PubMed ID: 1237952
    [No Abstract]   [Full Text] [Related]  

  • 20. The relation between twitch tension and action potential in plasmocid myopathy in the rat.
    Lee RG; Lambert EH
    Neurology; 1968 Mar; 18(3):274-5. PubMed ID: 5689671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.